Burning Rock Biotech Limited: cashflow_financing
| Value | {"unit": "CNY", "value": 1900000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | superseded |
| Entity | Burning Rock Biotech Limited |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:06:29.629507+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/86a3656e-af59-4a65-b3b1-c6154644251f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-183377Retrieved: 2026-08-19T18:06:29.629507+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001792267/cashflow-financing/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/86a3656e-af59-4a65-b3b1-c6154644251f
History
- no predecessors — first report